Changes in the Diagnosis of Extrapulmonary Tuberculosis During the COVID-19 Pandemic: Insights into Migrant Vulnerability in a Border Region - Report - MDSpire

Changes in the Diagnosis of Extrapulmonary Tuberculosis During the COVID-19 Pandemic: Insights into Migrant Vulnerability in a Border Region

  • By

  • Barış Çil

  • Mehmet Sinan Bodur

  • Mehmet Kabak

  • February 19, 2026

  • 0 min

Share

Clinical Report: Changes in the Diagnosis of Extrapulmonary Tuberculosis During the COVID-19 Pandemic

Overview

This study assesses the impact of the COVID-19 pandemic on tuberculosis (TB) diagnosis among local and migrant populations in Mardin, Turkey. It highlights significant decreases in TB case notifications and diagnostic challenges faced by migrant populations during the pandemic.

Background

Tuberculosis remains a critical global health issue, particularly among vulnerable populations such as migrants. The COVID-19 pandemic exacerbated existing barriers to healthcare access, leading to underdiagnosis and delayed treatment for TB. Understanding the effects of the pandemic on TB diagnosis is essential for improving health equity and response strategies in border regions.

Data Highlights

{'format': 'Ensure the table is properly formatted for clarity.'}

Key Findings

{'add_data': 'Include specific statistics to support findings.'}

Clinical Implications

Healthcare providers should prioritize equitable access to TB diagnostic services for migrant populations, especially in border regions. Enhanced screening and follow-up protocols are necessary to address the diagnostic gaps exacerbated by the COVID-19 pandemic.

Conclusion

The findings underscore the need for targeted public health interventions to improve TB diagnosis and treatment access for vulnerable populations, particularly in the context of ongoing health crises.

References

  1. World Health Organization, Global Tuberculosis Report 2023 -- Tuberculosis
  2. Infection, Geographical Factors Influence the Incidence of Extrapulmonary Tuberculosis: An Analysis of the Frankfurt TB Cohort from 2013 to 2018
  3. Infection, Increased Likelihood of Drug-Resistant Tuberculosis Among IGRA-Negative Contacts: Is Preventive Treatment Warranted?
  4. Infection, Variability in Clinical Presentation and Treatment Outcomes of Extrapulmonary Tuberculosis in a Low-Incidence Area: Findings from a Prospective Cohort Analysis
  5. The Journal of Infectious Diseases — Assessing Infectiousness and the Impact of Effective Treatment to Guide Isolation Recommendations for People With Pulmonary Tuberculosis
  6. WHO Consolidated Guidelines on Tuberculosis
  7. CDC Technical Instructions for Panel Physicians
  8. Tuberculosis

Original Source(s)

Related Content